Johns Hopkins: Spending on Consumer Advertising for Top-Selling Prescription Drugs in U.S. Favors Those With Low Added Benefit
February 08, 2023
February 08, 2023
BALTIMORE, Maryland, Feb. 8 (TNSjou) -- Johns Hopkins University's Bloomberg School of Public Health issued the following news release:
* * *
Analysis also revealed that majority of top-selling prescription drugs in the U.S.--more than two-thirds--are rated as having low added benefit compared to other drugs
* * *
A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health found that the share of promotional spend . . .
* * *
Analysis also revealed that majority of top-selling prescription drugs in the U.S.--more than two-thirds--are rated as having low added benefit compared to other drugs
* * *
A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health found that the share of promotional spend . . .